Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach
2018
Novel pharmacological therapies are in development for cancer, ranging from conventional chemotherapeutic drugs to molecular targeted drugs, antibody-based drugs, and immune checkpoint inhibitors, which are developed using new technologies. However, the increasing cost of new drug development is inc
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
61
References
5
Citations
NaN
KQI